JAK2 and myeloproliferative disorder: Here, we investigated EPO and thrombopoietin (TPO) induced SOCE and PLCγ1 activation in hematopoietic cells exhibiting activating mutations in JAK2 and CALR which are disease-initiating events in myeloproliferative neoplasms (MPNs).